145 related articles for article (PubMed ID: 34631791)
1. Corrigendum: Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling.
Zhuang C; Liu Y; Fu S; Yuan C; Luo J; Huang X; Yang W; Xie W; Zhuang C
Front Mol Biosci; 2021; 8():664616. PubMed ID: 34631791
[TBL] [Abstract][Full Text] [Related]
2. Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling.
Zhuang C; Liu Y; Fu S; Yuan C; Luo J; Huang X; Yang W; Xie W; Zhuang C
Front Mol Biosci; 2020; 7():616768. PubMed ID: 33363213
[TBL] [Abstract][Full Text] [Related]
3. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
4. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
[TBL] [Abstract][Full Text] [Related]
5. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.
Varelas X; Samavarchi-Tehrani P; Narimatsu M; Weiss A; Cockburn K; Larsen BG; Rossant J; Wrana JL
Dev Cell; 2010 Dec; 19(6):831-44. PubMed ID: 21145499
[TBL] [Abstract][Full Text] [Related]
6. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
Lee EH; Park KI; Kim KY; Lee JH; Jang EJ; Ku SK; Kim SC; Suk HY; Park JY; Baek SY; Kim YW
Phytomedicine; 2019 Sep; 62():152780. PubMed ID: 31121384
[TBL] [Abstract][Full Text] [Related]
7. Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer
Zhuang C; Zhuang C; Zhou Q; Huang X; Gui Y; Lai Y; Yang S
Front Mol Biosci; 2021; 8():646412. PubMed ID: 33816560
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.
Grannas K; Arngården L; Lönn P; Mazurkiewicz M; Blokzijl A; Zieba A; Söderberg O
J Mol Biol; 2015 Oct; 427(21):3407-15. PubMed ID: 25937570
[TBL] [Abstract][Full Text] [Related]
9. Modeling the Control of TGF-β/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap.
Labibi B; Bashkurov M; Wrana JL; Attisano L
iScience; 2020 Aug; 23(8):101416. PubMed ID: 32798968
[TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ Are Mechanoregulators of TGF-
Szeto SG; Narimatsu M; Lu M; He X; Sidiqi AM; Tolosa MF; Chan L; De Freitas K; Bialik JF; Majumder S; Boo S; Hinz B; Dan Q; Advani A; John R; Wrana JL; Kapus A; Yuen DA
J Am Soc Nephrol; 2016 Oct; 27(10):3117-3128. PubMed ID: 26961347
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
[TBL] [Abstract][Full Text] [Related]
12. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
Zhou X; Chen N; Xu H; Zhou X; Wang J; Fang X; Zhang Y; Li Y; Yang J; Wang X
J Hematol Oncol; 2020 Jun; 13(1):77. PubMed ID: 32546241
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
15. Correction to: LncRNA MIR497HG inhibits colorectal cancer progression by the miR-3918/
Tang G; Wu D; Guo M; Li H
J Genet; 2022; 101():. PubMed ID: 36443905
[TBL] [Abstract][Full Text] [Related]
16. Carvacrol ameliorates the progression of liver fibrosis through targeting of Hippo and TGF-β signaling pathways in carbon tetrachloride (CCl
Mohseni R; Karimi J; Tavilani H; Khodadadi I; Hashemnia M
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):163-171. PubMed ID: 30706740
[No Abstract] [Full Text] [Related]
17. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.
He C; Mao D; Hua G; Lv X; Chen X; Angeletti PC; Dong J; Remmenga SW; Rodabaugh KJ; Zhou J; Lambert PF; Yang P; Davis JS; Wang C
EMBO Mol Med; 2015 Nov; 7(11):1426-49. PubMed ID: 26417066
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer.
Kardooni H; Gonzalez-Gualda E; Stylianakis E; Saffaran S; Waxman J; Kypta RM
Cancers (Basel); 2018 May; 10(6):. PubMed ID: 29843383
[TBL] [Abstract][Full Text] [Related]
19. Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location.
Zhao MJ; Chen SY; Qu XY; Abdul-Fattah B; Lai T; Xie M; Wu SD; Zhou YW; Huang CZ
Curr Med Sci; 2018 Oct; 38(5):894-902. PubMed ID: 30341526
[TBL] [Abstract][Full Text] [Related]
20. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
